Results 231 to 240 of about 2,529,164 (287)
Some of the next articles are maybe not open access.
SLEEP
Abstract Introduction In a disproportionality analysis (Merino D, et al. J Clin Med. 2022;11:3890), sodium oxybate (SXB) treatment was associated with sleep-related eating disorder (SRED), a parasomnia characterized by somnambulism and compulsive eating. Immediate-release twice-nightly oxybate (TN-OXB)
L. Kass
openaire +2 more sources
Abstract Introduction In a disproportionality analysis (Merino D, et al. J Clin Med. 2022;11:3890), sodium oxybate (SXB) treatment was associated with sleep-related eating disorder (SRED), a parasomnia characterized by somnambulism and compulsive eating. Immediate-release twice-nightly oxybate (TN-OXB)
L. Kass
openaire +2 more sources
SLEEP
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) is approved to treat excessive daytime sleepiness and cataplexy in adult and pediatric patients ≥7 years of age with narcolepsy. The REFRESH study assesses the clinical effectiveness, patient satisfaction, and safety of ON-SXB for the
Sarah Meskill +9 more
openaire +2 more sources
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) is approved to treat excessive daytime sleepiness and cataplexy in adult and pediatric patients ≥7 years of age with narcolepsy. The REFRESH study assesses the clinical effectiveness, patient satisfaction, and safety of ON-SXB for the
Sarah Meskill +9 more
openaire +2 more sources
SLEEP
Abstract Introduction Sodium oxybate, available in once-nightly and twice-nightly formulations, is indicated for treatment of cataplexy or excessive daytime sleepiness in narcolepsy. Once-nightly sodium oxybate extended-release oral suspension (ON-SXB; LUMRYZ™) may alleviate potential dosing ...
Maggie Lavender +5 more
openaire +2 more sources
Abstract Introduction Sodium oxybate, available in once-nightly and twice-nightly formulations, is indicated for treatment of cataplexy or excessive daytime sleepiness in narcolepsy. Once-nightly sodium oxybate extended-release oral suspension (ON-SXB; LUMRYZ™) may alleviate potential dosing ...
Maggie Lavender +5 more
openaire +2 more sources
SLEEP
Abstract Introduction A novel once-nightly formulation of sodium oxybate (ON-SXB; LUMRYZ™) was investigated in patients with narcolepsy type 1 (NT1) and 2 (NT2) in the phase 3 REST-ON trial (NCT02720744).
Luis Ortiz +7 more
openaire +2 more sources
Abstract Introduction A novel once-nightly formulation of sodium oxybate (ON-SXB; LUMRYZ™) was investigated in patients with narcolepsy type 1 (NT1) and 2 (NT2) in the phase 3 REST-ON trial (NCT02720744).
Luis Ortiz +7 more
openaire +2 more sources
SLEEP
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) was investigated in patients with narcolepsy type 1 (NT1) or 2 (NT2) in the phase 3 REST-ON trial; treatment with 6, 7.5, and 9 g demonstrated significant improvements vs placebo (all P< 0.001) for the coprimary endpoints of ...
Michael Thorpy +7 more
openaire +2 more sources
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) was investigated in patients with narcolepsy type 1 (NT1) or 2 (NT2) in the phase 3 REST-ON trial; treatment with 6, 7.5, and 9 g demonstrated significant improvements vs placebo (all P< 0.001) for the coprimary endpoints of ...
Michael Thorpy +7 more
openaire +2 more sources
Clinical Neuropharmacology, 2018 Abstract Fluoxetine is a selective serotonin reuptake inhibitor that is commonly used in children and adolescents. Several reports exist regarding the relationship of fluoxetine use and sleep bruxism. We report the case of a 6-year-old girl who was successfully treated with once-nightly dosing of buspirone for fluoxetine-induced sleep bruxism,
Betül, Akbaş, Ayhan, Bilgiç
openaire +3 more sources
Long-term safety and efficacy of extended-release once-nightly sodium oxybate for narcolepsy
Sleep MedicineB.C. Corser +5 more
openaire +2 more sources
Dose titration of once-nightly sodium oxybate: analysis of interim data from RESTORE
Sleep MedicineA. Roy +5 more
openaire +2 more sources
Sleep
Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) is an extended-release formulation of sodium oxybate that eliminates the second, middle-of-the-night dose required by immediate-release twice-nightly oxybate (TN-OXB) formulations. RESTORE (NCT04451668)
S. Ibrahim +7 more
semanticscholar +1 more source
Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) is an extended-release formulation of sodium oxybate that eliminates the second, middle-of-the-night dose required by immediate-release twice-nightly oxybate (TN-OXB) formulations. RESTORE (NCT04451668)
S. Ibrahim +7 more
semanticscholar +1 more source